Literature DB >> 21801292

Isoform-specific localization of the deubiquitinase USP33 to the Golgi apparatus.

Christopher Thorne1, Rebecca L Eccles, Judy M Coulson, Sylvie Urbé, Michael J Clague.   

Abstract

Ubiquitin-specific protease 33 (USP33) is a deubiquitinase that has been associated with a variety of physiological events. Here, we show the existence of multiple USP33 splice variants and characterize the sub-cellular localization of endogenous USP33 as well as GFP-USP33 isoforms 1-3. The localization of USP33 is broadly confined to the secretory pathway, with all variants localizing to endoplasmic reticulum-associated structures. In addition, GFP-USP33 variant 3 shows a marked accumulation at the Golgi apparatus. Several deubiquitinases have large insertions within their otherwise highly conserved catalytic domains, the function of which is poorly characterized. Analysis of USP33 reveals a role for two distinct inserts within the catalytic domain. One is required for association with the endoplasmic reticulum, whilst the second is required for membrane association, but can be alternatively spliced (variant 3) to excise eight amino acids, which otherwise suppress Golgi localization. We propose that varying the expression of differentially localized isoforms provides a means to influence the spectrum of substrates encountered by USP33.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801292     DOI: 10.1111/j.1600-0854.2011.01261.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  14 in total

1.  The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response.

Authors:  Michal Simicek; Sam Lievens; Mathias Laga; Dmytro Guzenko; Vasily N Aushev; Peter Kalev; Maria Francesca Baietti; Sergei V Strelkov; Kris Gevaert; Jan Tavernier; Anna A Sablina
Journal:  Nat Cell Biol       Date:  2013-09-22       Impact factor: 28.824

2.  Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.

Authors:  Nickie C Chan; Willem den Besten; Michael J Sweredoski; Sonja Hess; Raymond J Deshaies; David C Chan
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 3.  Trafficking of β-Adrenergic Receptors: Implications in Intracellular Receptor Signaling.

Authors:  Qin Fu; Yang K Xiang
Journal:  Prog Mol Biol Transl Sci       Date:  2015-04-29       Impact factor: 3.622

4.  USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.

Authors:  Kaifeng Niu; Hongbo Fang; Zixiang Chen; Yuqi Zhu; Qunsong Tan; Di Wei; Yueyang Li; Adayabalam S Balajee; Yongliang Zhao
Journal:  Autophagy       Date:  2019-08-26       Impact factor: 16.016

5.  USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.

Authors:  Aili Zhang; Zhi Huang; Weiwei Tao; Kui Zhai; Qiulian Wu; Jeremy N Rich; Wenchao Zhou; Shideng Bao
Journal:  EMBO J       Date:  2022-02-22       Impact factor: 11.598

6.  USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.

Authors:  Ji Li; Vincenzo D'Angiolella; E Scott Seeley; Sehyun Kim; Tetsuo Kobayashi; Wenxiang Fu; Eric I Campos; Michele Pagano; Brian David Dynlacht
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

Review 7.  Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling.

Authors:  Adriano Marchese; Joann Trejo
Journal:  Cell Signal       Date:  2012-11-29       Impact factor: 4.315

Review 8.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

Review 9.  The business of deubiquitination - location, location, location.

Authors:  Erin S Coyne; Simon S Wing
Journal:  F1000Res       Date:  2016-02-11

10.  Integration of cellular ubiquitin and membrane traffic systems: focus on deubiquitylases.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  FEBS J       Date:  2017-01-29       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.